Physician profile
Kory J Johnson
NPI 1952539603
$79,144.13
in general payments reported to CMS, 2019-2025
13 companies · $9,766 in 2025
The $9,766 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $8,983 · 2021: $17K · 2022: $8,175 · 2023: $16K · 2024: $4,523 · 2025: $9,766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Food and Beverage: $1,026 · Travel and Lodging: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,497.37 |
| Food and Beverage | $1,026.45 |
| Travel and Lodging | $776.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $68,939.13 | 2019-2025 | Reclaim, Pinnacle Gription, Pinnacle |
| Depuy Synthes Products, INC. | $6,748.46 | 2019-2023 | Reclaim, Pinnacle, Pinnacle Gription |
| Depuy Synthes Sales INC. | $1,760.48 | 2019-2025 | Attune |
| Zimmer Biomet Holdings, INC. | $1,144.76 | 2019-2025 | Persona, Tapestry |
| Bioventus LLC | $163.96 | 2019 | |
| Sanara Medtech INC. | $110.74 | 2025 | Celleraterx |
| Smith+Nephew, INC. | $61.71 | 2020 | |
| Davol INC. | $56.15 | 2024-2025 | Arista Ah Flexitip, Arista |
| Stryker Corporation | $47.47 | 2022 | |
| Boston Scientific Corporation | $36.61 | 2023-2025 | Ekosonic |
| Ge Healthcare | $35.79 | 2019 | |
| Abbott Laboratories | $33.31 | 2024 | Proclaim |
| Embody, INC. | $5.56 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kory Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.